ANAVEX LIFE SCIENCES CORP. (AVXL) › Operating IncomeANAVEX LIFE SCIENCES CORP. (AVXL) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$5.65M2011: -$6.18M2012: -$4.32M2013: -$2.14M2014: -$2.97M2020: -$31.09M2021: -$42.00M2022: -$50.99M2023: -$55.76M2024: -$52.88M2025: -$51.41M-$51.41M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$51.41M+2.8%2024-$52.88M+5.2%2023-$55.76M-9.4%2022-$50.99M-21.4%2021-$42.00M-35.1%2020-$31.09M—2014-$2.97M-38.9%2013-$2.14M+50.5%2012-$4.32M+30.1%2011-$6.18M-9.4%2010-$5.65M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share